Chief executives at both Labcorp and Quest Diagnostics reported year-over-year revenue growth in the first quarter during recent earnings calls, especially in specialty and consumer testing. They also indicated the companies are watching the progress of the RESULTS Act in Congress in hopes that it will reform the unpopular Protecting Access to Medicare Act (PAMA). […]
Labcorp and Quest Execs Support RESULTS Act Progress
National clinical laboratory companies report Q1 revenue growth with an emphasis on specialty testing
- By Mark Terry
- > From the Volume XXXIII, No. 8 - June, 2026 Issue
- Tags: earnings, LabCorp, PAMA, Quest Diagnostics, Results Act, specialty testing
